Unsung hero
Accamma Cherian
She left teaching to join the freedom struggle and led a vast peaceful rally when Travancore's leaders were arrested. Gandhi called her the Jhansi Rani of Travancore.
KRM Ayurveda Ltd
₹ 283
-2.53%
14 Aug
- close price
About
Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India.[1]
Key Points
- Market Cap ₹ 601 Cr.
- Current Price ₹ 283
- High / Low ₹ 344 / 156
- Stock P/E 23.9
- Book Value ₹ 54.0
- Dividend Yield 0.00 %
- ROCE 35.3 %
- ROE 29.0 %
- Face Value ₹ 10.0
Unsung hero
Swami Brahmanand
He was jailed multiple times for participating in the Salt Satyagraha, Non-Cooperation Movement, and Quit India Movement. He was a social reformer and established teaching institutes such as Brahmanand Inter College (1938), Brahmanand Sanskrit Mahavidyalaya (1943) and Brahmanand Mahavidyalaya (1960).
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 36.7%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 56.5 to 81.6 days.
- Working capital days have increased from 131 days to 280 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Part of Nifty SME Emerge
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 89 | 67 | 77 | 102 | |
| 78 | 60 | 57 | 71 | |
| Operating Profit | 11 | 8 | 19 | 30 |
| OPM % | 13% | 11% | 25% | 30% |
| 0 | 0 | 0 | 1 | |
| Interest | 1 | 2 | 2 | 3 |
| Depreciation | 1 | 1 | 1 | 1 |
| Profit before tax | 10 | 5 | 16 | 27 |
| Tax % | 25% | 28% | 26% | 25% |
| 8 | 3 | 12 | 20 | |
| EPS in Rs | 5,066.67 | 2,273.33 | 806.67 | 9.46 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 4% |
| TTM: | 33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 38% |
| TTM: | 66% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 37% |
| Last Year: | 29% |
Balance Sheet
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 0.15 | 0.15 | 0.15 | 21 |
| Reserves | 8 | 12 | 24 | 93 |
| 20 | 23 | 31 | 0 | |
| 11 | 9 | 12 | 8 | |
| Total Liabilities | 39 | 44 | 67 | 122 |
| 23 | 23 | 27 | 26 | |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 38 |
| 16 | 21 | 40 | 58 | |
| Total Assets | 39 | 44 | 67 | 122 |
Cash Flows
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 4 | -1 | -0 | 1 | |
| -23 | -0 | -4 | -30 | |
| 19 | 1 | 6 | 37 | |
| Net Cash Flow | 0 | 0 | 2 | 7 |
| Free Cash Flow | -20 | -1 | -5 | 0 |
| CFO/OP | 36% | 33% | 14% | 29% |
Ratios
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 32 | 30 | 58 | 82 |
| Inventory Days | 13 | 53 | 296 | 225 |
| Days Payable | 100 | 141 | 205 | 80 |
| Cash Conversion Cycle | -55 | -58 | 149 | 227 |
| Working Capital Days | 9 | 48 | 64 | 280 |
| ROCE % | 22% | 42% | 35% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Bed Capacity count |
|
|||
| Number of Hospitals count |
||||
| Revenue Share of Services % |
||||
| Total Employees count |
||||
| Number of Clinics count |
||||
| Number of Physicians count |
||||
| Average Revenue per Occupied Bed (ARPOB) INR |
||||
| Bed Occupancy Rate % |
||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Monitoring Agency Report
- CARE monitoring report flags revised IPO allocation, 3.86 crore working-capital overutilisation, and traceability concerns.
-
Updates
- Q1 FY27 unaudited results: total income Rs 3,286.55 lakh, PAT Rs 908.45 lakh, submitted 10 Aug 2026.
-
Outcome of Board Meeting
- Board approved Q1 FY27 unaudited results on 10 Aug 2026; profit rose to Rs 9.08 crore.
-
Updates
- Acquired 100% of Karma Nutravedics for ₹1 lakh; became wholly owned subsidiary on 03 July 2026.
-
Reply to Clarification- Financial results
- KRM Ayurveda filed missing FY26 financial result clarifications, working capital certificate, and unmodified audit opinion.
Concalls
-
Jun 2026TranscriptAI SummaryPPT
-
May 2026Transcript PPT
Business Profile[1]
KRM Ayurveda Limited operates an integrated Ayurvedic healthcare platform combining multispecialty hospitals, clinics, teleconsultation services, and in-house Ayurvedic medicine manufacturing.